Monash-led team secures funding to develop graphene oxide sensor for early cancer detection
Monash Health and Monash University have received a $100,000 research grant from the Love Your Sister Foundation, through the Monash Health Foundation, to develop a graphene oxide (GO)-based biosensor for early cancer detection using circulating tumor DNA (ctDNA). The GO-ctDNA project is a large interdisciplinary collaboration spanning oncology, engineering, nanofabrication and structural biology across Monash Health, Monash University and national research facilities.
“This project represents a perfect convergence of engineering innovation and clinical need,” said Dr. Gwo Yaw Ho, Head of the Cancer Immunology Laboratory within the School of Clinical Sciences at Monash Health, Monash University. “If successful, our GO-ctDNA biosensor could revolutionize early cancer diagnostics by offering a simple, non-invasive blood test that detects cancer mutations with unprecedented sensitivity, potentially even before symptoms appear.”

